Empasita
Diabetes
Empasita
Empagliflozin + sitagliptin
About Empasita
Empasita combines empagliflozin, an SGLT2 inhibitor, with sitagliptin, a DPP-4 inhibitor, in one tablet for adults with type 2 diabetes.
Prescription-only medicine. This information is intended for healthcare professionals. Always follow the approved product information and the advice of a doctor or pharmacist.
